G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2006
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257880 Gastric and prostate cancer associated antigens
11/16/2006	US20060257879 Methods and kits for detecting an enzyme capable of modifying a nucleic acid
11/16/2006	US20060257875 Affinity screening using "one-bead-one-compound" libraries
11/16/2006	US20060257870 Cdkl 1 as modifier of branching morphogenesis and methods of use
11/16/2006	US20060257869 for stimulation of angiogenesis
11/16/2006	US20060257866 Methods for identifying small molecules that modulate premature translation termination and nonsense mediated mrna decay
11/16/2006	US20060257865 Method for identification and development of therapeutic agents
11/16/2006	US20060257863 Viral detection method using viral encoded enzymes and chemiluminescent substrates
11/16/2006	US20060257862 A highly cost-effective analytical device for performing immunoassays with ultra high sensitivity
11/16/2006	US20060257857 Methods for identifying functionally related genes and drug targets
11/16/2006	US20060257856 Heterodimeric receptor libraries using phagemids
11/16/2006	US20060257855 Biological particulate matter analogue
11/16/2006	US20060257854 Membrane assay system including preloaded particles
11/16/2006	US20060257850 Methods of treatment and diagnosis of patients with hepatitis c infection
11/16/2006	US20060257846 Method of assaying for high performance mammals
11/16/2006	US20060257843 Kappa-PVIIA-related conotoxins as organ protectants
11/16/2006	US20060257842 Cryopreservation media and molecules
11/16/2006	US20060257558 Plasma polymerization of atomically modified surfaces
11/16/2006	US20060257536 Method for determining a moment in a preparation process of food at which the food has reached a ready state
11/16/2006	US20060257418 Vaccine
11/16/2006	US20060257410 Inhibit binding of a competitor antibody to CCX-CKR2 (chemokine receptors), competitor antibody comprises the complementarity determining region (CDR); cancer, angiogenesis and arthritis
11/16/2006	US20060257409 Breast Specific Genes and Proteins
11/16/2006	US20060257408 Method for influencing kinase pathways with IL-22
11/16/2006	US20060257405 Diagnostics and therapeutics for diseases associated with aryl hydrocarbon receptor (ahr)
11/16/2006	US20060257404 Modulators of the P2Y10 receptor useful in altering T lymphocyte function
11/16/2006	US20060257402 Use of soluble cd164 in inflammatory and/or autoimmune disorders
11/16/2006	US20060257319 Method for in vivo determination on tested animals of the efficient concentration of deuterium depleted water for cancer therapy
11/16/2006	US20060257318 Method for the in vitro assessment of the progression status of an infection by an hiv virus in an individual
11/16/2006	US20060257287 Robust system for screening enclosed spaces for biological agents
11/16/2006	US20060257013 System and methods for rapid and automated screening of cells
11/16/2006	US20060256340 Method and a system for determination of particles in a liquid sample
11/16/2006	US20060254932 Electrochemical cell
11/16/2006	US20060254911 Gas sensor module with contactless interface
11/16/2006	US20060254909 Electrode and sensor using same
11/16/2006	US20060254374 Method for the quantification of hydrophilic properties of porous materials
11/16/2006	US20060254371 Apparatus and method for collecting soil solution samples
11/16/2006	DE4192629B4 Donated blood collection and processing system - comprises two porous media interposed between a collection bag and two satellite bags
11/16/2006	DE20221607U1 Testing device comprises a signal producing unit emitting an electrical signal having a predetermined frequency spectrum and electrically coupled to a sample, and an outlet via which the signal is output with the sample
11/16/2006	DE202006013102U1 Sample chamber for analysis of influences on cell cultures in plate cone rheometer located on flat-parallel culture plate, comprises culture plate carrying barrier layer occupied with cell adhesion molecules or fragments of a fusion protein
11/16/2006	DE202006009728U1 Microarray assembly includes microporous membrane having different analyte-specific capture molecules (proteins, antibodies or nucleic acids), and incubation chamber arrangement
11/16/2006	DE19956466B4 Vorrichtung zur Überwachung chemischer Substanzen in Rauchgas Device for monitoring of chemical substances in flue gas
11/16/2006	DE102005023055A1 Making DNA fragments for determining DNA methylation pattern involves digesting DNA with methylation-specific restriction enzyme; and ligating adapters to restriction fragments, followed by primer mediated-amplification of ligated fragments
11/16/2006	DE102005022439A1 Objective soft biological tissue surface point turgor estimation procedure includes estimation of depth of penetration by marker ball object under preset force
11/16/2006	DE102005022432A1 Sensor for biological warfare agent, has stimulation laser for production of laser-induced surface plasma on contaminated sample, and spectrometer for spectroscopy of radiation that is raised
11/16/2006	DE102005022182A1 Modulatoren der PDZ-Domäne Modulators of the PDZ domain
11/16/2006	DE102004012524B4 Verfahren zur Bestimmung wahrer Molekülmassen von Konstituenten biologischer Proben Method for the determination of true molecular masses of the constituents of biological samples
11/16/2006	DE10155707B4 Massenbestimmung für Biopolymere Mass determination of biopolymers
11/16/2006	DE10010282B4 Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben Process for detection of cytosine methylation in DNA samples
11/16/2006	CA2651367A1 Methods of enriching fetal cells
11/16/2006	CA2619079A1 Method of stabilizing pulmonary surfactant protein
11/16/2006	CA2612137A1 Method and apparatus for determining anticoagulant therapy factors
11/16/2006	CA2608315A1 Use of a new gene coding for a new member of the mcm2-8 family in pharmaceutical compositions
11/16/2006	CA2608241A1 Assessment of weather damage in cereal grains
11/16/2006	CA2608068A1 Novel steroid 5 .alpha.-reductase
11/16/2006	CA2607863A1 Affinity adsorbents for fibrinogen
11/16/2006	CA2607858A1 Affinity adsorbents for factor viii and von willebrand's factor
11/16/2006	CA2607851A1 Affinity adsorbents for plasminogen
11/16/2006	CA2607832A1 Auxiliary method for diagnosis and therapy of cancer with nucleolin
11/16/2006	CA2607799A1 Use of antibody-ligand binding to characterise diseases
11/16/2006	CA2607569A1 Compositions and methods for modulating cells via cd14 and toll-like receptor 4 signaling pathway
11/16/2006	CA2607513A1 High-resolution tracking of industrial process materials using trace incorporation of luminescent markers
11/16/2006	CA2607285A1 Diagnosis of liver pathology through assessment of protein glycosylation
11/16/2006	CA2606916A1 Liquid crystal based analyte detection
11/16/2006	CA2606812A1 Diagnostic marker for diabetic vascular complications
11/16/2006	CA2606723A1 Multiplex capture of nucleic acids
11/16/2006	CA2606548A1 Measurement of binding rate of a binding substance and an analyte
11/16/2006	CA2606287A1 Peptide
11/16/2006	CA2605247A1 Devices and methods for diagnosing or predicting early stage cardiac dysfunctions
11/16/2006	CA2605151A1 Determination of responders to chemotherapy
11/16/2006	CA2507420A1 Improved statistical methods applied to surface chemistry in minerals flotation
11/15/2006	EP1722374A1 Method for determining the state of activation of a protein
11/15/2006	EP1722236A1 Bead dispensing system
11/15/2006	EP1722233A2 Screening method for different indications comprising BNPI and/or DNPI
11/15/2006	EP1722232A1 Devices and methods for diagnosing or predicting early stage cardiac dysfunctions
11/15/2006	EP1722231A2 Method for identification of somatic stem cells
11/15/2006	EP1722230A2 Method for detection of a disease-specific combinatorial molecular pattern motif in a tissue sample of a patient's skin
11/15/2006	EP1722229A1 Method of assessing risk of and predisposition to the development of a pathology related to the presence of anti-epcr antibodies
11/15/2006	EP1722228A1 Immobilized biomolecule and method of detecting substance capable of interacting with biomolecule
11/15/2006	EP1722227A2 Epitopes formed by non-covalent association of conjugates
11/15/2006	EP1722226A1 Method of distinguishing type a and type b acute aortic dissection and acute myocardial infarction and kit for distinguishment
11/15/2006	EP1722225A1 A method for diagnosing immunity recurrent spontaneous abortion and method for treating and monitoring
11/15/2006	EP1722224A1 Method of evaluating the transprency and moisture retention of horny layer by using oxidized protein in the horny layer as indication
11/15/2006	EP1722223A1 Metal oxide membrane with a gas-selective compound
11/15/2006	EP1722222A1 Method of determining impurity in acrylic acid
11/15/2006	EP1722219A1 Gas sensor
11/15/2006	EP1721991A1 Method of detecting nucleic acid and utilization thereof
11/15/2006	EP1721985A1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles
11/15/2006	EP1721979A1 Compositions and methods for increasing bone mineralisation
11/15/2006	EP1721978A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof
11/15/2006	EP1721977A2 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
11/15/2006	EP1721972A2 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna
11/15/2006	EP1721971A1 Screening method
11/15/2006	EP1721968A1 In vitro tumor angiogenesis model
11/15/2006	EP1721609A2 Pyridylpyrimidine derivatives as effective compounds against prion infections and prion diseases
11/15/2006	EP1721283A2 Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential
11/15/2006	EP1721167A1 Biomarker detection assays
11/15/2006	EP1721166A1 Methods for screening insecticides
11/15/2006	EP1721165A2 New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis
11/15/2006	EP1721164A2 Diagnostics and therapeutics for diseases associated with arginyl aminopeptidase rnpep-like (rnpep-like)

1 ... 1780 1781 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 1798 1799 1800 ... 3937